Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cambria Pharmaceuticals Inc.

www.cambriapharma.com

Latest From Cambria Pharmaceuticals Inc.

Start-Up Previews (07/2008)

A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Glioblastoma Start-Ups Get Specific," "Glaucoma Start-Ups Reach Critical Mass," and "ALS on the Cusp." Plus these Start-Ups Across Health Care: EarlySense, NeoChord, and Pantec Biosolutions.

Cambria Pharmaceuticals Inc.

Although only a small percentage of ALS cases seem tied to the mutant form of SOD1, the deep knowledge about it provides Cambria Pharmaceuticals with a platform for assaying compounds it intends to develop against ALS and other neurodegenerative diseases.
BioPharmaceutical

ALS on the Cusp

Amyotrophic lateral sclerosis, the devastating neurodegenerative disease, has largely defied R&D efforts, but emerging knowledge, much of it through nonprofit research organizations, raises hopes for better results and treatments with blockbuster potential. In this issue we profile two emerging drug developers hoping to make an impact: Cambria Pharmaceuticals and Knopp Neurosciences.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Cambria Biosicences LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cambria Pharmaceuticals Inc.
  • Senior Management
  • Leo Liu, MD, Pres. & CEO
    Donald Kirsch, PhD, SVP, Drug Discovery
  • Contact Info
  • Cambria Pharmaceuticals Inc.
    Phone: (781) 938-1333
    8A Henshaw St.
    Woburn, MA 01801
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register